-
1
-
-
26844519681
-
Alterations of stress genes and immediate early gene expression following focal ischemia in brain
-
Moskowitz MA, Caplan LR, eds. Boston, Oxford, Melbourne, Singapore, Toronto, Munich, New Delhi, Tokyo: Butterworth-Heinemann
-
Sharp FR, Kinouchi H, Massa S, Swanson RA, Koistinaho J, Sagar SM et al. Alterations of stress genes and immediate early gene expression following focal ischemia in brain. I: Moskowitz MA, Caplan LR, eds. Cerebrovascular diseases. Nineteenth Princeton Stroke Conference. Boston, Oxford, Melbourne, Singapore, Toronto, Munich, New Delhi, Tokyo: Butterworth-Heinemann, 1995: 219-30.
-
(1995)
Cerebrovascular Diseases. Nineteenth Princeton Stroke Conference
, pp. 219-230
-
-
Sharp, F.R.1
Kinouchi, H.2
Massa, S.3
Swanson, R.A.4
Koistinaho, J.5
Sagar, S.M.6
-
2
-
-
0026558430
-
Stroke incidence in Copenhagen, 1976-1988
-
Lindenstrøm E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976-1988. Stroke 1992; 23: 28-32.
-
(1992)
Stroke
, vol.23
, pp. 28-32
-
-
Lindenstrøm, E.1
Boysen, G.2
Nyboe, J.3
Appleyard, M.4
-
4
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
5
-
-
0028871958
-
Low-molecular-weight heparin for the treatment of acute ischemic stroke
-
Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja FL et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995; 333: 1588-93.
-
(1995)
N Engl J Med
, vol.333
, pp. 1588-1593
-
-
Kay, R.1
Wong, K.S.2
Yu, Y.L.3
Chan, Y.W.4
Tsoi, T.H.5
Ahuja, F.L.6
-
6
-
-
26844555415
-
Forebyggelse af hjernesygdomme
-
Sundhedsstyrelsen.
-
Sundhedsstyrelsen. Forebyggelse af hjernesygdomme. Apopleksia cerebri. Kobenhavn: Sundhedsstyrelsen 1996; 8: 23-33.
-
(1996)
Apopleksia Cerebri. Kobenhavn: Sundhedsstyrelsen
, vol.8
, pp. 23-33
-
-
-
7
-
-
0025347391
-
Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
-
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
-
(1990)
Lancet
, vol.335
, pp. 827-838
-
-
Collins, R.1
Peto, R.2
MacMahon, S.3
Hebert, P.4
Fiebach, N.H.5
Eberlein, K.A.6
-
8
-
-
0029558921
-
Influence of systolic and diastolic blood pressure on stroke risk: A prospective study
-
Lindenstrom E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective study. Am J Epidemiol 1995; 142: 1279-90.
-
(1995)
Am J Epidemiol
, vol.142
, pp. 1279-1290
-
-
Lindenstrom, E.1
Boysen, G.2
Nyboe, J.3
-
9
-
-
0029001533
-
Smoking cessation and the risk of stroke in middle-aged men
-
Wannamethee SC, Shaper G, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995; 274: 155-60.
-
(1995)
JAMA
, vol.274
, pp. 155-160
-
-
Wannamethee, S.C.1
Shaper, G.2
Whincup, P.H.3
Walker, M.4
-
10
-
-
0028177645
-
Influence of total cholesterol, high density lipoprotein cholesterol and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study
-
Lindenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 1994; 309: 11-5.
-
(1994)
BMJ
, vol.309
, pp. 11-15
-
-
Lindenstrøm, E.1
Boysen, G.2
Nyboe, J.3
-
11
-
-
0028244264
-
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-1457
-
-
-
12
-
-
0025869608
-
MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
-
European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-43.
-
(1991)
Lancet
, vol.337
, pp. 1235-1243
-
-
|